PAIGE KEOUGH: Open Payments
NPI 1134852593 · HUNTERSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 35 payments from 15 companies in 2025. Trend: 2023 $717 · 2024 $2,032 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $214 |
| Regeneron Healthcare Solutions, Inc. | 5 | $172 |
| CSL Behring | 4 | $105 |
| ABBVIE INC. | 3 | $64 |
| Genentech USA, Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Siemens Medical Solutions USA, Inc. | 1 | $29 |
| Azurity Pharmaceuticals, Inc. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| GENZYME CORPORATION | 1 | $23 |
Products named: DUPIXENT, TEZSPIRE, Hizentra, BOTOX, Xolair, FASENRA, BREZTRI, Andembry.
Industry payments across NC — which companies pay providers there.
